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This report describes a hitherto unreported anionic background current from human atrial cardiomyocytes. Under whole-cell patch-
clamp with anion-selective conditions, an outwardly rectifying anion current (IANION) was observed, which was larger with iodide than
nitrate, and with nitrate than chloride as charge carrier. In contrast with a previously identiﬁed background anionic current from small
mammal cardiomyocytes, IANION was not augmented by the pyrethroid teﬂuthrin (10 lM); neither was it inhibited by hyperosmolar
external solution nor by DIDS (200 lM); thus IANION was not due to basal activity of volume-sensitive anion channels. IANION was par-
tially inhibited by the Cl channel blockers NPPB (50 lM) and Gly H-101 (30 lM). Incorporation of IANION into a human atrial action
potential (AP) simulation led to depression of the AP plateau, accompanied by alterations to plateau inward calcium current, and to AP
shortening at 50% but not 90% of complete repolarization, demonstrating that IANION can inﬂuence the human atrial AP proﬁle.
 2007 Elsevier Inc.
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Open access under CC BY-NC-ND license.The electrophysiological behaviour of cardiac myocytes
from mammalian hearts is determined by the combined
activity of a range of diﬀerent cation and anion channel
types. The reversal potential for chloride (Cl) ions in the
heart (ECl) lies between 60 and 40 mV [1]. Negative
to ECl outward Cl
 movement generates depolarizing ionic
current, whilst positive to ECl inward Cl
 movement gener-
ates repolarizing ionic current. Therefore, the activation of
Cl channels can inﬂuence both the resting membrane
potential and the duration of cardiac action potentials
(APs) ([1–3] for reviews). Several diﬀerent anion channel
types have been identiﬁed that may contribute to cardiac
physiology and pathophysiology [1–3]. Of the cardiac0006-291X 2007 Elsevier Inc.
doi:10.1016/j.bbrc.2007.05.177
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Open access under CC BY-NC-ND license.anion channel currents thus far identiﬁed, the three major
types are: (i) a cystic ﬁbrosis transmembrane conductance
regulator (CFTR) current-activated through cAMP-depen-
dent phosphorylation (ICl,cAMP; e.g. [4–6]); (ii) a stretch- or
swelling-activated Cl current (ICl,Swell; e.g. [7–9]) and (iii)
a Ca2+-activated Cl current (ICl,Ca; e.g. [10–12]).
Recently, an outwardly rectifying anionic background
current (IAB) has been identiﬁed in cardiac myocytes from
two commonly studied model species (rat and guinea-pig)
using whole-cell patch-clamp measurements [13,14]. IAB is
distinct from previously identiﬁed Cl currents as it has a
distinct permeability sequence ðNO3 > I > ClÞ and is
insensitive to the stilbene diphosphonate Cl channel
inhibitor DIDS, to cell swelling and to intracellular Ca2+
and cAMP [13,14]. IAB can also be diﬀerentiated from
other major cardiac anion currents as it can be activated
by the pyrethroid agent teﬂuthrin [14]. Anion substitution
experiments have provided evidence that IAB can inﬂuence
AP duration (APD) [13]. There is some disagreement as to
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human atrium [15,16] and there is no information as to
whether humans exhibit an IAB with the characteristics of
that seen in small mammal hearts. Therefore, the present
study was undertaken to determine whether or not IAB
exists in adult human cardiac myocytes. The resulting ﬁnd-
ings indicate the presence in human atrial myocytes of an
outwardly rectifying anionic background current (IANION).
Notably, the IANION observed in this study has the poten-
tial to contribute to human atrial electrophysiology, but is
distinct from both the IAB recorded previously from myo-
cytes from small mammal hearts [13,14] and from out-
wardly rectifying stilbene diphosphonate-sensitive anionic
currents recorded previously from human atrium [17].Methods
Atrial myocyte isolation
The study was approved by the local Central and South Bristol
Research Ethics Committee and was conducted in accordance with the
principles of the Declaration of Helsinki. Human right atrial appendages
were obtained, with consent, from 32 patients (27 males, 5 females,
average age 69.7 ± 1.7 years) undergoing coronary artery bypass surgery.
Single human atrial myocytes were isolated from right atrial appendages
by mechanical and enzymatic dispersion. Tissue samples were quicklyTable 1
Composition of solutions used in this study
Chemical Solution (concentration, mM)
A1 B2 C2 D2
NaCl 145   
KCl 4   
MgCl2 1 2.5 2.5 2.5
CaCl2 2   
Glucose 10 10 10 10
HEPES 10 5 5 5
NMDG-Cl  135  
NMDG-Aspartate   135 
NMDG-I    135
NMDG-NO3    
TEACl  5 5 5
BaCl2  2 2 2
CdCl2  0.5 0.5 0.5
Sucrose    
Cs glutamate    
CsCl    
CsEGTA    
MgATP (tris-salt)    
Tris-phosphocreatine    
Tris-GTP    
Pyruvic acid    
4Pipes    
Adenosine    
EGTA    
KH2PO4    
Mannitol    
MgSO4    
Cl concentration 155 150 15 15
Osmolarity (mOsm) 308 ± 2.5 305 ± 1.2 306 ± 0.3 310 ± 3
Osmolarities for each solution are measured values (see Methods).
Note. pH 7.4 with 1NaOH, 2CsOH, 3KOH; 4pH 7.1 with CsCO3. Minus signimmersed in cardioplegic solution (see Table 1; solution G, 100% O2, ice
cold). The samples were chopped into small chunks and washed with an
EGTA-containing solution (see Table 1; solution H) gassed with 100% O2
for 15 min at 37 C. The chunks were then incubated in the same solution
from which EGTA was excluded and protease type XXIV (3 U/ml, Sigma)
and collagenase type V (250 U/ml, Sigma) were added. The medium was
continuously gassed with 100% O2 at 37 C. After 15 min, the incubation
medium was substituted for the same solution containing collagenase only.
Myocytes were progressively released from the chunks into the superna-
tant and their yield monitored under a microscope. The suspension was
washed in enzyme-free solution and the myocytes were stored at room
temperature until use (within 8 h of cell isolation).Electrophysiology
Solutions used. Experimental solutions for the investigation of anionic
current were similar to those used previously to study IAB [14]; the com-
position of all solutions used is given in Table 1. Osmolarity values given
for each of the solutions listed in Table 1 were measured using a micro-
osmometer employing a freezing-point method (Advanced Instruments,
Norwood, MA, USA). Myocytes used in whole-cell voltage-clamp
experiments were superfused (20–25 C) with a standard Hepes-buﬀered
Tyrode’s solution (see Table 1; solution A) until the whole-cell recording
conﬁguration had been obtained. For isolation of background anion
current, sodium-free Tyrode’s solutions were used (solutions B–E) in
which Na was replaced by N-methyl-D-glucamine (NMDG), with one of
several possible dominant anions: solution B, chloride; solution C,
aspartate; solution D, iodide; solution E, nitrate. All drugs used were
added to solution E from stock solutions made in dimethyl sulfoxideE2 F2 G3 H1 I2
   137 
    
2.5 2.5   0.5
    
10 10 140 10 
5 5 10 5 
    
    
    
135 135   
5 5   
2 2   
0.5 0.5   
 70   
    75
    20
    0.05
    10
    5
    0.1
    5
    30
  5  
   0.2 
  50 5 
  100  
  8 1 
15 15 0 137 21
305 ± 0.2 365 ± 1.5 383 ± 0.3 282 ± 0.6 308 ± 1.2
indicates absence.
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Fig. 1. (A) Representative anion-sensitive whole-cell currents (I, normal-
ized to membrane capacitance) evoked by 500 ms depolarizing ramps from
90 to +70 mV from a holding potential of 50 mV (see inset) during
superfusion with external solutions containing diﬀerent anions (solutions
C, B, E or D, respectively). (B) Representative Cl, NO3
 and I-sensitive
current (I) for the same cell calculated by subtracting the current recorded
during depolarizing ramps in the presence of aspartate from those in the
presence of Cl, NO3
 or I, respectively. (C) Mean normalized values of
anion currents obtained at +60 mV (NO3
, n = 7; Cl, n = 7; I, n = 6.
*p < 0.05; **p < 0.001 compared to NO3
).
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dihydroxyphenyl)methylene)glycine hydrazide (Gly H-101), which was
solved in distilled water. The hyperosmotic external solution (solution F)
was prepared by adding 70 mM sucrose to solution E. A Cs-based pipette
solution (solution I) was used for all experiments. Solution I was sodium-
free to prevent contamination of chloride currents by the sodium–calcium
exchanger current.
Drugs. Diisothiocyanostilbene-2,2 0-disulfonic acid (DIDS, ﬁnal con-
centration 200 lM), 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB,
ﬁnal concentration 50 lM) and teﬂuthrin (TEF, ﬁnal concentration
10 lM) were purchased from Sigma Chemical Co. (Poole, UK). N-(2-
naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine
hydrazide (Gly H-101, ﬁnal concentrations of 10 and 30 lM) was pur-
chased from Merck (Frankfurt, Germany). All the drug-containing solu-
tions were protected from light throughout.
Electrophysiological recording
In electrophysiological experiments, junction potential changes were
minimized by immersing the reference Ag/AgCl electrode in a 3 M KCl
solution with a continuous agar bridge (4% agar in 3 M KCl). Borosilicate
glass pipettes (Harvard Apparatus, UK) were pulled using a vertical two-
step Narishige PP-830 microelectrode puller (Narishige, Japan) and had a
tip resistance of 5–7 MX when ﬁlled with the pipette solution. During
anion substitution experiments, background anion current was elicited
from voltage-clamped myocytes (superfused with solutions B, C, D and E
in the whole-cell conﬁguration) by depolarizing ramps from 90 to
+70 mV from a holding potential of 50 mV (ramp rate of 0.32 V s1;
sweep duration 1.03 s). A holding potential of 50 mV was used to
inactivate the Na+-current and T-type Ca2+-current.
Recordings were made using an Axopatch 200A ampliﬁer, and data
were recorded on computer using pClamp v. 9.0 software (Axon Instru-
ments, Forster City, CA). Data were analyzed using the Clampﬁt program
of pClamp v. 9.0.
Mean values of averaged original signals over ﬁve command pulses were
used for statistical analysis. Hyperpolarizing voltage steps of 20 mV and
5 ms duration were applied at 20 Hz to record the capacitance transients
required for direct integration and the calculation of cell capacitance. The
statistical signiﬁcance between control and the drug periods or NO3
 and
other anions were determined by the Paired Student’s t-test using either
Microsoft Excel or GraphPad Prism v. 4.0. The statistical signiﬁcance
between the normal and hyperosmotic NO3
 solutions was calculated with
two-way ANOVA test using GraphPad Prism v. 4.0. Statistical signiﬁcance
was considered to refer to the 95% level of conﬁdence (p < 0.05).
Human atrial action potential simulations
The Courtemanche et al. human atrial action potential (AP) model [18]
was modiﬁed to incorporate a formulation for IANION based on the
experimental data obtained with NO3
 and Cl in Figs. 1 and 2. Readers
are referred to [18] for the general equations required to set up the model.
The following equation was used to simulate anionic background current
(IANION)
IANION ¼ gANION
ðV  EANIONÞ
1 c eðdðVEANIONÞÞ ð1Þ
where EANION represents the current reversal potential and gANION is the
conductance of IANION. By ﬁtting Eq. (1) to experimental data shown in
Fig. 1B and scaled to the mean data shown in Fig. 2A, we obtained
gANION = 0.37 pS/pF, EANION =45.64 mV, c= 0.87, d = 8.4 · 104 mV1
for the NO3
-sensitive IANION, and gANION = 0.19 pS/pF, c = 0.94,
d= 2.5 · 104 mV1 for the Cl-sensitive IANION.
Results and discussion
The voltage protocol used for these experiments was
similar to that used previously to study IAB present incardiomyocytes from small mammal hearts [14] and is
shown as an inset to Fig. 1A. From a holding potential
of 50 mV, ascending voltage ramps were applied between
90 and +70 mV. This protocol was applied to cells super-
fused ﬁrst with aspartate (Asp)-containing solution (solu-
tion C) and then with diﬀerent superfusates containing
more permeant anions. Fig. 1A shows an example of the
net current traces obtained from a cell superfused serially
with solutions containing Asp, Cl, NO3
 and I. Both
inward and, particularly, outward current components
were greater with Cl, NO3
 and I than with Asp in
the external superfusate. Fig. 1B shows current traces for
the same cell, obtained by subtracting the current in Asp
from that with each of the more permeant anions. With
each of Cl, NO3
 and I, the Asp-sensitive diﬀerence
current showed marked outward rectiﬁcation. Fig. 1C
compares the mean outward current amplitude at
+60 mV (normalized to membrane capacitance) for the
three anions. Compared to NO3
, the observed current
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Fig. 2. (A) Plot of the mean I–V relations of NO3
-sensitive current
(solution E, n = 19). (B) Plot of the mean I–V relations of NO3
-sensitive
current recorded in hyperosmolar solution (solution F, n = 8, p > 0.05 vs.
NO3
 of normal osmolarity (solution E), two-way ANOVA). (C) Eﬀects
of drugs on NO3
-sensitive current at +60 mV, expressed as percentage of
the control current value before the addition of the drug (NO3
, n = 15,
NPPB (50 lM), n = 5, Gly H-101 (30 lM), n = 8, Gly H-101 (10 lM),
n = 4, DIDS (200 lM), n = 5 and TEF (10 lM), n = 8. *p < 0.05;
**p < 0.001 compared to NO3
).
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charge carrier. These observations support the presence
in human atrial cells of a basally active, anionic current
(IANION); however, the relative current amplitudes with
the three permeant anions diﬀer from those observed
previously with for the IAB observed in myocytes from
guinea-pig and rat hearts, where IAB was largest with
NO3
 (permeability sequence NO3
 > I > Cl; [13,14]).
Fig. 2A shows the mean IANION–voltage relation for 19
atrial cells, with NO3
 as the major external anion (with
IANION measured as the NO3
  Asp diﬀerence current).
The mean current–voltage relation for the resulting current
showed clear outward rectiﬁcation, with an observed rever-
sal potential (Erev) for IANION in these experiments of
45.7 ± 2.2 mV (obtained by pooling Erev values from
individual experiments). Previous studies provide evidence
that human atrial cells exhibit ICl, Swell (e.g. [15,17,19–21]).Therefore, in order to determine whether or not IANION
could be attributed to basal activity of channels mediating
ICl,Swell, Asp
 to NO3
 substitutions were also made using
hyperosmolar external solution [14]. The mean data from
eight such experiments are shown in Fig. 2B. There was
no statistically signiﬁcant diﬀerence between the plotted
densities of IANION from the I–V relation obtained in hyp-
erosmolar solution and that shown in Fig. 2A, suggesting
that IANION is distinct from ICl,Swell.
In order to characterize further IANION from human
atrial myocytes, the sensitivity of the current to a range
of pharmacological interventions was tested. Fig. 2C sum-
marises the eﬀects of the various interventions (expressed
as % changes in NO3
-sensitive current at +60 mV). The
stilbene disulphonate DIDS failed to inhibit IANION at a
concentration (200 lM) that would be anticipated to inhi-
bit ICl,Swell [19,21]. On the other hand, teﬂuthrin (10 lM),
which we have previously reported to activate the IAB seen
in myocytes from guinea-pig hearts [14], failed to alter sig-
niﬁcantly the amplitude of IANION from human atrial myo-
cytes. Together with the relative IANION amplitudes in I
,
Cl and NO3
, the lack of eﬀect of teﬂuthrin indicates that
IANION is distinct from the previously reported rat/guinea-
pig IAB [13,14]. Moreover, the lack of signiﬁcant inhibition
of the current by DIDS or hyperosmolar solution makes
the IANION observed in the present study distinct from
ICl,Swell [1] and from an osmolarity- and stilbene-sensitive
outwardly rectifying chloride current recently reported by
Demion and colleagues [17]. NPPB (50 lM) produced a
partial, statistically signiﬁcant (p < 0.05) inhibition of
IANION. The glycine hydrazide Cl
 channel inhibitor Gly
H-101 failed to produce a signiﬁcant blockade of IANION
at 10 lM (7-fold greater than the reported IC50 for
CFTR channel inhibition at +60 mV [22]); but produced
partial attenuation of the current at 30 lM (20-fold the
reported IC50 for CFTR [22]). Evidence for the presence
of CFTR (ICa,cAMP) in human atrial cells is mixed
[1,15,19–21,23], with a number of studies failing to observe
the current in response to b-adrenergic stimulation, for-
skolin or cAMP (e.g. [15,19–21]). Previous work has failed
to ﬁnd evidence for ICl,Ca in human atrial myocytes [24]
and, moreover, the presence of EGTA in the pipette dialy-
sate (Table 1, solution I) and external [Ca2+] replacement
in our experiments would have inhibited any [Ca2+]i-acti-
vated conductances on membrane depolarization. There-
fore, the IANION seen here appears to diﬀer not only from
guinea-pig and rat IAB [13,14] but also from the three major
reported cardiac anion conductances in: (i) being basally
active and (ii) its overall pharmacological proﬁle and sensi-
tivity to anion substitution.
In order to gain insight into the physiological role of
IANION, the current was incorporated into human atrial
AP simulations as outlined in the ‘Methods’. Fig. 3A shows
the simulated APs (at an AP frequency of 1 Hz) from the
Courtemanche et al. model [18] both without (Control)
and with inclusion of IANION, whilst Fig. 3B shows the cor-
responding current proﬁles during the time-course of the
Fig. 3. (A) Simulated human atrial action potentials with and without
(Control) inclusion of IANION (with each of NO3
 and Cl as charge
carrier). (B) Proﬁle of IANION during each of the action potentials shown
in panel A. (C) Proﬁle of L-type Ca2+ current (ICa,L) during each of the
action potentials shown in panel A, in control and with NO3
-dependent
and Cl-dependent IANION.
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 and Cl as charge carrier, incorpo-
ration of IANION into the model produced shortening of AP
duration at 50% repolarization (APD50; the measured
APD50 values were 184, 165 and 159 ms for Control, Cl-
sensitive IANION and NO3-sensitive IANION, respectively).
In contrast, APD90 was comparatively unaﬀected (the mea-
sured APD90 was 305 ms under each condition) and rest-
ing potential also changed relatively little (with resting
potential values of 81, 79 and 78 mV, respectively,
for Control, IANION with Cl
 and IANION with NO3
).
The more marked eﬀect of IANION inclusion at less negative
potentials during AP repolarization is concordant with the
outwardly rectifying nature of the current. An additional
observation made from the AP simulations is that incorpo-
ration of IANION also inﬂuenced the proﬁle of L-type cal-
cium current (ICa,L) during the AP plateau: the initial
rapid component of ICa,L was unaﬀected by IANION incor-
poration, but the sustained component during the AP pla-
teau showed a modest reduction. Thus, both an increase in
repolarizing current carried by IANION and the consequent
decrease in the sustained component of ICa,L combined to
lead to AP plateau depression and abbreviation of
APD50. The results shown in Fig. 3 demonstrate clearly
that IANION is able to inﬂuence human atrial AP repolari-
zation. Further work is now warranted to determine boththe extent to which the incorporation/omission of IANION
inﬂuences the susceptibility of human atrial cells and tissue
to arrhythmia and to pursue the underlying identity and
regulation of this novel background conductance.
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